Literature DB >> 33539985

Multidimensional frailty increases cardiovascular risk in older people: An 8-year longitudinal cohort study in the Osteoarthritis Initiative.

Nicola Veronese1, Ai Koyanagi2, Lee Smith3, Clarissa Musacchio4, Lisa Cammalleri4, Mario Barbagallo5, Alberto Pilotto6.   

Abstract

BACKGROUND: Cardiovascular diseases (CVDs) are the most important cause of mortality and an important cause of disability. Frailty seems to be associated with higher cardiovascular risk, but limited research has been done using a multidimensional approach to frailty. Thus, the present study aimed to investigate whether the multidimensional prognostic index (MPI), based on comprehensive geriatric assessment (CGA), is associated with CVD risk in the Osteoarthritis Initiative (OAI) study.
METHODS: Community-dwellers affected by knee OA or at high risk for this condition were followed for 8 years. A standardized CGA including information on functional, nutritional, mood, comorbidities, medications, quality of life and co-habitation status was used to calculate a modified version of the MPI (range 0-1), with higher scores representing greater risk of mortality. CVDs were recorded using self-reported information. Logistic regression analyses, adjusting for potential confounders, were conducted.
RESULTS: The final sample consisted of 4211 individuals (mean age 60.8 years, females = 58.6%). People with incident CVD had a significant higher baseline MPI value than those without CVD (0.44 ± 0.17 vs. 0.39 ± 0.17). People with an MPI between 0.34 and 0.66 (OR = 1.31; 95%CI: 1.03-1.67) and over 0.66 (OR = 1.91; 95%CI: 1.26-2.89) experienced a higher risk of CVD (vs. MPI score < 0.34). A 0.10 points increase in the MPI score at baseline was associated with a 1.16 (95%CI: 1.09-1.24) times higher odds for incident CVD. CONCLUSIONS AND IMPLICATIONS: Higher MPI values at baseline were associated with an increased risk of CVD, reinforcing the importance of CGA in predicting CVD risk in older people.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Cardiovascular risk; Comprehensive geriatric assessment; Multidimensional prognostic index; Osteoarthritis Initiative

Year:  2021        PMID: 33539985     DOI: 10.1016/j.exger.2021.111265

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  5 in total

1.  Vascular Age, Metabolic Panel, Cardiovascular Risk and Inflammaging in Patients With Rheumatoid Arthritis Compared With Patients With Osteoarthritis.

Authors:  Gabriel-Santiago Rodríguez-Vargas; Pedro Santos-Moreno; Jaime-Andrés Rubio-Rubio; Paula-Katherine Bautista-Niño; Darío Echeverri; Luz-Dary Gutiérrez-Castañeda; Fabio Sierra-Matamoros; Stephania Navarrete; Anggie Aparicio; Luis Saenz; Adriana Rojas-Villarraga
Journal:  Front Cardiovasc Med       Date:  2022-07-05

2.  Frailty index and risk of cardiovascular diseases: a mendelian randomization study.

Authors:  Jun Li; Heng Chen; Wei He; Limin Luo; Xiaogang Guo
Journal:  Ann Transl Med       Date:  2022-09

3.  Multidimensional prognostic index and the risk of fractures: an 8-year longitudinal cohort study in the Osteoarthritis Initiative.

Authors:  Nicola Veronese; Lee Smith; Ekaterini Zigoura; Mario Barbagallo; Ligia J Dominguez; Antonella Barone; Alberto Cella; Cyrus Cooper; Renè Rizzoli; Jean-Yves Reginster; Stefania Maggi; Alberto Pilotto
Journal:  Arch Osteoporos       Date:  2021-12-14       Impact factor: 2.879

4.  Multidimensional frailty and quality of life: data from the English Longitudinal Study of Ageing.

Authors:  Nicola Veronese; Marianna Noale; Alberto Cella; Carlo Custodero; Lee Smith; Marina Barbagelata; Stefania Maggi; Mario Barbagallo; Carlo Sabbà; Luigi Ferrucci; Alberto Pilotto
Journal:  Qual Life Res       Date:  2022-05-17       Impact factor: 3.440

5.  Frailty and cardiovascular outcomes in the National Health and Aging Trends Study.

Authors:  Abdulla A Damluji; Shang-En Chung; Qian-Li Xue; Rani K Hasan; Mauro Moscucci; Daniel E Forman; Karen Bandeen-Roche; Wayne Batchelor; Jeremy D Walston; Jon R Resar; Gary Gerstenblith
Journal:  Eur Heart J       Date:  2021-10-01       Impact factor: 35.855

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.